Correlation Between Health Biotchnology and Midcap Fund

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Health Biotchnology and Midcap Fund at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Health Biotchnology and Midcap Fund into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Health Biotchnology Portfolio and Midcap Fund R 3, you can compare the effects of market volatilities on Health Biotchnology and Midcap Fund and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Health Biotchnology with a short position of Midcap Fund. Check out your portfolio center. Please also check ongoing floating volatility patterns of Health Biotchnology and Midcap Fund.

Diversification Opportunities for Health Biotchnology and Midcap Fund

-0.48
  Correlation Coefficient

Very good diversification

The 3 months correlation between Health and Midcap is -0.48. Overlapping area represents the amount of risk that can be diversified away by holding Health Biotchnology Portfolio and Midcap Fund R 3 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Midcap Fund R and Health Biotchnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Health Biotchnology Portfolio are associated (or correlated) with Midcap Fund. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Midcap Fund R has no effect on the direction of Health Biotchnology i.e., Health Biotchnology and Midcap Fund go up and down completely randomly.

Pair Corralation between Health Biotchnology and Midcap Fund

Assuming the 90 days horizon Health Biotchnology is expected to generate 10.53 times less return on investment than Midcap Fund. But when comparing it to its historical volatility, Health Biotchnology Portfolio is 1.04 times less risky than Midcap Fund. It trades about 0.03 of its potential returns per unit of risk. Midcap Fund R 3 is currently generating about 0.32 of returns per unit of risk over similar time horizon. If you would invest  4,240  in Midcap Fund R 3 on August 31, 2024 and sell it today you would earn a total of  303.00  from holding Midcap Fund R 3 or generate 7.15% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Health Biotchnology Portfolio  vs.  Midcap Fund R 3

 Performance 
       Timeline  
Health Biotchnology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Health Biotchnology Portfolio has generated negative risk-adjusted returns adding no value to fund investors. In spite of fairly strong forward indicators, Health Biotchnology is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Midcap Fund R 

Risk-Adjusted Performance

18 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Midcap Fund R 3 are ranked lower than 18 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly weak primary indicators, Midcap Fund may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Health Biotchnology and Midcap Fund Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Health Biotchnology and Midcap Fund

The main advantage of trading using opposite Health Biotchnology and Midcap Fund positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Health Biotchnology position performs unexpectedly, Midcap Fund can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Midcap Fund will offset losses from the drop in Midcap Fund's long position.
The idea behind Health Biotchnology Portfolio and Midcap Fund R 3 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.

Other Complementary Tools

Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Stocks Directory
Find actively traded stocks across global markets
Bonds Directory
Find actively traded corporate debentures issued by US companies
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes